Associate Director, Talent Management

About the role

We are seeking a results-driven Associate Director of Talent Management to lead the architecture and execution of the global talent strategy for Menarini Stemline. In this high-impact leadership role, you will move beyond tactical execution to implement global talent tools that identify, develop, and retain our most critical asset: our people. You will act as a strategic partner to senior leadership, ensuring our internal talent pipeline supports our 3–5-year business goals. Additionally, you will create and execute robust development and career pathways, partner with Talent Acquisition to build an employer brand that attracts top-tier talent, and co-design an onboarding program to help new hires become productive quickly.

This position is classified as a corporate office role. Under the New York employer convenience rule, Stemline will withhold New York state income taxes for all corporate office employees, regardless of work location.

Responsibilities

• Executive Talent & Capability Architecture
  • Lead the annual Talent & Capability Planning cycle, aligning workforce evolution with the company’s long-term strategic plan.
  • Identify the "skills of the future" required for competitiveness and design interventions to build them internally.
  • Integrate the company’s Core Values and Patient-Centricity into all talent touchpoints, ensuring alignment with ethical and compliance standards.
• Advanced Succession & Readiness Management
  • Facilitate high-level Talent Review Sessions with the executive suite, ensuring objective calibration and a culture of meritocracy.
  • Implement sophisticated assessment frameworks (e.g., 360-evaluations, behavioral assessments) to determine "Ready Now" status for key critical positions and successors.
  • Build and maintain the Succession Plan for the organization’s most critical roles, minimizing "key person" risk and ensuring leadership continuity.
• Managerial Excellence & Leadership Coaching
  • Oversee the curriculum for mid-to-senior level Manager Skill Development, shifting focus from "managing tasks" to "leading people and strategy."
  • Act as a shadow coach to high-potential leaders, guiding them through complex transitions and leadership challenges.
  • Manage external vendor relationships for executive coaching and specialized training modules.
• High-Potential (HiPo) Development
  • Design the framework for customized, high-touch Individual Development Plans (IDPs) for identified key talent, incorporating stretch assignments, mentorship, and formal education.
  • Drive a "talent first" culture where high-performers are proactively considered for movement across functions to broaden their business acumen.

Requirements

• 8–10+ years in Talent Management, Organizational Development, or HR Leadership, with at least 3 years in a people-management or high-level strategic role.
• Ideal candidate from a Biotech or Pharma company, with a few years in a biotech environment expected.
• Proven ability to collaborate with the Global Menarini HR team to refine Group programs for Oncology business needs.
• Demonstrated ability to present to and influence Executive-level stakeholders with data-backed insights.
• Proficiency in using talent analytics to predict turnover, identify flight risks, and measure the health of the talent pipeline.

Success Metrics

• Internal Fill Rate: Percentage of leadership roles filled by internal successors.
• Talent Bench Strength: Ratio of "Ready Now" successors for critical positions.
• Retention of High-Potentials: Turnover rate among the identified "Key Talent" segment.

Pay

Base Salary Range: $146,286–$185,400.

Benefits

• Short- and Long-Term Incentive Programs.
• Fidelity 401(k) with a 6% company match.
• Anthem Premier PPO and HDHP insurance plans.
• Company-paid Basic Life & AD&D insurance.
• Pre-tax FSA/HSA programs.

About Us

Founded in 1886 in Naples as Farmacia Internazionale, Menarini moved to Florence in 1915, where its headquarters remain today. The Menarini Group is an Italian pharmaceutical company with nearly 135 years of history, operating in 70 countries with products sold in 140 locations. With around 18,000 employees, Menarini produces over 500 million packs of drugs annually across 18 manufacturing sites, including a biotech plant for monoclonal antibodies.

Menarini has a strong commitment to oncology, with a pipeline of five investigational compounds for hematological and solid tumors. The acquisition of Stemline Therapeutics in 2020 strengthened its oncology portfolio, adding commercial and clinical-stage assets. Key products include Tagraxofusp, the first and only approved CD123-targeted therapy for blastic plasmacytoid dendritic cell neoplasm (BPDCN), and Elacestrant, an oral SERD approved for hormone receptor-positive advanced breast cancer. Menarini also holds exclusive rights to commercialize Selinexor for oncology indications in Europe, Latin America, and other regions.